MindWalk Holdings Corp. has announced a significant financial move by entering into a $30 million revolving credit facility. This agreement, made with Sanabil (Cayman), aims to bolster the company’s working capital and support general corporate purposes. The facility allows MindWalk to borrow up to $7.5 million per quarter, reflecting a strategic approach to enhance liquidity in a competitive market.

The revolving credit facility matures in 36 months, with the possibility of a 12-month extension if mutually agreed upon. This financial maneuver is particularly noteworthy as it underscores the increasing need for flexible financing solutions within the pharmaceutical preparations industry, where companies are often required to manage substantial operational costs.

Background

MindWalk Holdings Corp., identified by its CIK number 0001715925, operates within the pharmaceutical preparations sector (SIC: 2834). The company is publicly traded on the Nasdaq under the ticker symbol HYFT. Recently, it has filed several reports, including a 6-K on November 17, 2026, detailing this latest credit agreement.

What the Filing Says

According to the filing, "On November 16, 2026, MindWalk Holdings Corp. entered into a Senior Unsecured Revolving Credit Agreement with Sanabil (Cayman). The Credit Agreement provides for a senior unsecured revolving credit facility in an aggregate principal amount of up to $30.0 million." The company will pay interest at a fixed rate of 7.00% per annum, with an initial fee of $300,000 paid to the lender.

Impact

This credit facility is expected to enhance MindWalk's operational flexibility, allowing it to respond more effectively to market demands and investment opportunities. The arrangement may also influence other companies in the pharmaceutical preparations sector, prompting them to consider similar financing strategies to maintain competitive advantage.

What's Next

The filing does not say what happens next.